
Pharmascience
North America, Quebec, Canada, Montréal
Description
Pharmascience is a manufacturer of generic drugs.
Investor Profile
Pharmascience has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Israel, Canada.
- Strong thematic focus on Pharmaceutical, Biotechnology, Health Care.
Stage Focus
- Private Equity (20%)
- Series B (20%)
- Series Unknown (20%)
- Post Ipo Equity (20%)
- Series A (20%)
Country Focus
- United States (60%)
- Israel (20%)
- Canada (20%)
Industry Focus
- Pharmaceutical
- Biotechnology
- Health Care
- Clinical Trials
- Manufacturing
- Therapeutics
- Medical
- Health Diagnostics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.